Recon: FDA warns Aspen Pharmacare for sterility issues at major facility; EMA OKs AI tool in fatty liver disease studies
ReconJason Scott
Artificial intelligence/machine learning (AI/ML)Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaNutritional/Natural HealthPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesWarning letters